Show simple item record

dc.contributor.authorCarney, Christine
dc.contributor.authorKapur, Anshika
dc.contributor.authorAnastasiadis, Pavlos
dc.contributor.authorChen, Chixiang
dc.contributor.authorWoodworth, Graeme
dc.contributor.authorWinkles, Jeffrey W.
dc.contributor.authorKim, Anthony
dc.date.accessioned2022-06-13T20:07:37Z
dc.date.available2022-06-13T20:07:37Z
dc.date.issued2022
dc.identifier.urihttp://hdl.handle.net/10713/19140
dc.descriptionPoster presented at the Controlled Release Society Annual Meeting, July 11-15, 2022 and the Cancer Biology Research Retreat, June 9, 2022en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshNanoparticles--therapeutic useen_US
dc.subject.meshTWEAK Receptoren_US
dc.subject.meshTriple Negative Breast Neoplasmsen_US
dc.subject.meshBrain Neoplasmsen_US
dc.titleNanotherapeutic targeting of the Fn14 receptor for TNBC brain metastases (2)en_US
dc.typePoster/Presentationen_US
refterms.dateFOA2022-06-13T20:07:38Z


Files in this item

Thumbnail
Name:
SOP_Carney(2)_2022.pdf
Size:
859.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International